Cargando…

Decision-analytic modeling for early health technology assessment of medical devices – a scoping review

OBJECTIVE: The goal of this review was to identify decision-analytic modeling studies in early health technology assessments (HTA) of high-risk medical devices, published over the last three years, and to provide a systematic overview of model purposes and characteristics. Additionally, the aim was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conrads-Frank, Annette, Schnell-Inderst, Petra, Neusser, Silke, Hallsson, Lára R., Stojkov, Igor, Siebert, Silke, Kühne, Felicitas, Jahn, Beate, Siebert, Uwe, Sroczynski, Gabi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869403/ https://www.ncbi.nlm.nih.gov/pubmed/36742459 http://dx.doi.org/10.3205/000313

Ejemplares similares

Causal evidence in health decision making: methodological approaches of causal inference and health decision science
por: Kühne, Felicitas, et al.
Publicado: (2022)

Occupational therapy for persons with cognitive impairments
por: Schnell-Inderst, Petra, et al.
Publicado: (2023)

Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations
por: Hallsson, Lára R., et al.
Publicado: (2023)

Vergleich der Effektivität von multiplen dynamischen Behandlungsstrategien unter Nutzung der Target-Trial-Emulierung: Kontrafaktischer Ansatz zur Kausalinferenz aus Real-World-Daten
por: Kuehne, Felicitas, et al.
Publicado: (2023)

Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review
por: Sroczynski, Gaby, et al.
Publicado: (2020)

Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis
por: Grill, Eva, et al.
Publicado: (2005)

Evaluation criteria for health apps supporting medication adherence in early-stage technology development – a scoping review
por: Niemann, Anja, et al.
Publicado: (2023)

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany
por: Sroczynski, Gaby, et al.
Publicado: (2010)

Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia
por: Vukićević, Đurđa, et al.
Publicado: (2020)

Measurement of fractional flow reserve to guide decisions for percutaneous coronary intervention
por: Siebert, Uwe, et al.
Publicado: (2008)

Screening of the hearing of newborns - Update
por: Schnell-Inderst, Petra, et al.
Publicado: (2006)

Economic evaluation of newborn hearing screening: modelling costs and outcomes
por: Hessel, Franz, et al.
Publicado: (2003)

Extracorporal hemodialysis with acute or decompensated chronical hepatic failure
por: Hessel, Franz, et al.
Publicado: (2006)

Stool DNA testing for early detection of colorectal cancer: systematic review using the HTA Core Model(®) for Rapid Relative Effectiveness Assessment
por: Stürzlinger, Heidi, et al.
Publicado: (2023)

Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone – efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment
por: Schnell-Inderst, Petra, et al.
Publicado: (2022)

POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study
por: Jahn, B, et al.
Publicado: (2022)

P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study
por: Jahn, B., et al.
Publicado: (2022)

Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment
por: Siebert, Uwe, et al.
Publicado: (2003)

Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
por: Siebert, Uwe
Publicado: (2005)

Individual health services
por: Schnell-Inderst, Petra, et al.
Publicado: (2011)

Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events
por: Schnell-Inderst, Petra, et al.
Publicado: (2009)

Pharmacogenomics Bias - Systematic distortion of study results by genetic heterogeneity
por: Siebert, Uwe, et al.
Publicado: (2008)

Why should we apply ABM for decision analysis for infectious diseases?—An example for dengue interventions
por: Miksch, Florian, et al.
Publicado: (2019)

HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
por: Mühlberger, Nikolai, et al.
Publicado: (2009)

The Optimizing-Risk-Communication (OptRisk) randomized trial – impact of decision-aid-based consultation on adherence and perception of cardiovascular risk
por: Adarkwah, Charles Christian, et al.
Publicado: (2019)

HPR171 COVID 19 Vaccination - How to Support Decisions on Vaccination Prioritization for New Variants of Concern?
por: Jahn, B, et al.
Publicado: (2022)

The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany
por: Schaffner, Monika, et al.
Publicado: (2020)

Application of Decision-Analytic Models in Personalized Medicine for CML Treatment Decisions Made by Payers, Providers, and Patients
por: Saverno, Kim R., et al.
Publicado: (2012)

An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply
por: Bicher, Martin, et al.
Publicado: (2022)

Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online
por: Jahn, Beate, et al.
Publicado: (2017)

Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failure
por: Schnell-Inderst, Petra, et al.
Publicado: (2006)

On the role of data, statistics and decisions in a pandemic
por: Jahn, Beate, et al.
Publicado: (2022)

Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation
por: Jahn, Beate, et al.
Publicado: (2021)

Authors’ response: on the role of data, statistics and decisions in a pandemic
por: Jahn, Beate, et al.
Publicado: (2022)

Patient‐reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis
por: Stauder, Reinhard, et al.
Publicado: (2020)

Discrete choice experiment to determine preferences of decision-makers in healthcare for different formats of rapid reviews
por: Speckemeier, Christian, et al.
Publicado: (2021)

The Impact of Electronic Patient Portals on Patient Care: A Systematic Review of Controlled Trials
por: Ammenwerth, Elske, et al.
Publicado: (2012)

Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group
por: Rochau, Ursula, et al.
Publicado: (2020)

Problems and Barriers Related to the Use of Digital Health Applications: Protocol for a Scoping Review
por: Giebel, Godwin Denk, et al.
Publicado: (2022)

Time-to-event versus ten-year-absolute-risk in cardiovascular risk prevention – does it make a difference? Results from the Optimizing-Risk-Communication (OptRisk) randomized-controlled trial
por: Adarkwah, Charles Christian, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a68b9bedhng9o7e676h0ufj78e